Home >> Instrumentation & Equipment >> Healthcare >> Food & Beverage >>

Global Biologics and Biosimilars Market Trend, Status and Outlook 2018-2023

Published: Mar-2018 | Format: PDF | MIReports | Number of pages: 149 | Code: MRS - 296423

Report Summary

Biologics and Biosimilars Market Status and Trend Report 2018-2023 offers a comprehensive analysis on Biologics and Biosimilars industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Global and Regional Market Size of Biologics and Biosimilars 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Biologics and Biosimilars worldwide, with company and product introduction, position in the Biologics and Biosimilars market
Market status and development trend of Biologics and Biosimilars by types and applications
Cost and profit status of Biologics and Biosimilars, and marketing status
Market growth drivers and challenges

The report segments the global Biologics and Biosimilars market as:

Global Biologics and Biosimilars Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2018-2023):
North America
Europe
China
Japan
Rest APAC
Latin America

Global Biologics and Biosimilars Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2018-2023):
Biologics
Biosimilars

Global Biologics and Biosimilars Market: Application Segment Analysis (Consumption Volume and Market Share 2018-2023; Downstream Customers and Market Analysis)
Tumor
Diabetes
Cardiovascular
Others

Global Biologics and Biosimilars Market: Manufacturers Segment Analysis (Company and Product introduction, Biologics and Biosimilars Sales Volume, Revenue, Price and Gross Margin):
Pfizer
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Novo Nordisk
Novartis

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table of Contents
Chapter 1 Overview of Biologics and Biosimilars
    1.1 Definition of Biologics and Biosimilars in This Report
    1.2 Commercial Types of Biologics and Biosimilars
        1.2.1 Biologics
        1.2.2 Biosimilars
    1.3 Downstream Application of Biologics and Biosimilars
        1.3.1 Tumor
        1.3.2 Diabetes
        1.3.3 Cardiovascular
        1.3.4 Others
    1.4 Development History of Biologics and Biosimilars
    1.5 Market Status and Trend of Biologics and Biosimilars 2013-2023
        1.5.1 Global Biologics and Biosimilars Market Status and Trend 2013-2023
        1.5.2 Regional Biologics and Biosimilars Market Status and Trend 2013-2023
Chapter 2 Global Market Status and Forecast by Regions
    2.1 Market Development of Biologics and Biosimilars 2013-2017
    2.2 Production Market of Biologics and Biosimilars by Regions
        2.2.1 Production Volume of Biologics and Biosimilars by Regions
        2.2.2 Production Value of Biologics and Biosimilars by Regions
    2.3 Demand Market of Biologics and Biosimilars by Regions
    2.4 Production and Demand Status of Biologics and Biosimilars by Regions
        2.4.1 Production and Demand Status of Biologics and Biosimilars by Regions 2013-2017
        2.4.2 Import and Export Status of Biologics and Biosimilars by Regions 2013-2017
Chapter 3 Global Market Status and Forecast by Types
    3.1 Production Volume of Biologics and Biosimilars by Types
    3.2 Production Value of Biologics and Biosimilars by Types
    3.3 Market Forecast of Biologics and Biosimilars by Types
Chapter 4 Global Market Status and Forecast by Downstream Industry
    4.1 Demand Volume of Biologics and Biosimilars by Downstream Industry
    4.2 Market Forecast of Biologics and Biosimilars by Downstream Industry
Chapter 5 Market Driving Factor Analysis of Biologics and Biosimilars
    5.1 Global Economy Situation and Trend Overview
    5.2 Biologics and Biosimilars Downstream Industry Situation and Trend Overview
Chapter 6 Biologics and Biosimilars Market Competition Status by Major Manufacturers
    6.1 Production Volume of Biologics and Biosimilars by Major Manufacturers
    6.2 Production Value of Biologics and Biosimilars by Major Manufacturers
    6.3 Basic Information of Biologics and Biosimilars by Major Manufacturers
        6.3.1 Headquarters Location and Established Time of Biologics and Biosimilars Major Manufacturer
        6.3.2 Employees and Revenue Level of Biologics and Biosimilars Major Manufacturer
    6.4 Market Competition News and Trend
        6.4.1 Merger, Consolidation or Acquisition News
        6.4.2 Investment or Disinvestment News
        6.4.3 New Product Development and Launch
Chapter 7 Biologics and Biosimilars Major Manufacturers Introduction and Market Data
    7.1 Pfizer
        7.1.1 Company profile
        7.1.2 Representative Biologics and Biosimilars Product
        7.1.3 Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of Pfizer
    7.2 Roche
        7.2.1 Company profile
        7.2.2 Representative Biologics and Biosimilars Product
        7.2.3 Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of Roche
    7.3 Amgen
        7.3.1 Company profile
        7.3.2 Representative Biologics and Biosimilars Product
        7.3.3 Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of Amgen
    7.4 AbbVie
        7.4.1 Company profile
        7.4.2 Representative Biologics and Biosimilars Product
        7.4.3 Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of AbbVie
    7.5 Sanofi
        7.5.1 Company profile
        7.5.2 Representative Biologics and Biosimilars Product
        7.5.3 Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of Sanofi
    7.6 Johnson & Johnson
        7.6.1 Company profile
        7.6.2 Representative Biologics and Biosimilars Product
        7.6.3 Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of Johnson & Johnson
    7.7 Novo Nordisk
        7.7.1 Company profile
        7.7.2 Representative Biologics and Biosimilars Product
        7.7.3 Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of Novo Nordisk
    7.8 Novartis
        7.8.1 Company profile
        7.8.2 Representative Biologics and Biosimilars Product
        7.8.3 Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of Novartis
Chapter 8 Upstream and Downstream Market Analysis of Biologics and Biosimilars
    8.1 Industry Chain of Biologics and Biosimilars
    8.2 Upstream Market and Representative Companies Analysis
    8.3 Downstream Market and Representative Companies Analysis
Chapter 9 Cost and Gross Margin Analysis of Biologics and Biosimilars
    9.1 Cost Structure Analysis of Biologics and Biosimilars
    9.2 Raw Materials Cost Analysis of Biologics and Biosimilars
    9.3 Labor Cost Analysis of Biologics and Biosimilars
    9.4 Manufacturing Expenses Analysis of Biologics and Biosimilars
Chapter 10 Marketing Status Analysis of Biologics and Biosimilars
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List
Chapter 11 Report Conclusion
Chapter 12 Research Methodology and Reference
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Reference


List of Tables

    Table Advantage and Disadvantage of Biologics
    Table Advantage and Disadvantage of Biosimilars
    Table Production Volume of Biologics and Biosimilars by Regions 2013-2017
    Table Production Value of Biologics and Biosimilars by Regions 2013-2017
    Table Demand Volume of Biologics and Biosimilars by Regions 2013-2017
    Table Production and Demand Status of Biologics and Biosimilars in Region One 2013-2017
    Table Production and Demand Status of Biologics and Biosimilars in Region Two 2013-2017
    Table Production and Demand Status of Biologics and Biosimilars in Region Three 2013-2017
    Table Production and Demand Status of Biologics and Biosimilars in Region Four 2013-2017
    Table Import Volume of Biologics and Biosimilars by Regions 2013-2017
    Table Export Volume of Biologics and Biosimilars by Regions 2013-2017
    Table Production Volume of Biologics and Biosimilars by Types 2013-2017
    Table Production Value of Biologics and Biosimilars by Types 2013-2017
    Table Production Volume Forecast of Biologics and Biosimilars by Types 2018-2023
    Table Production Value Forecast of Biologics and Biosimilars by Types 2018-2023
    Table Demand Volume of Biologics and Biosimilars by Downstream Industry 2013-2017
    Table Demand Volume Forecast of Biologics and Biosimilars by Downstream Industry 2018-2023
    Table Production Volume of Biologics and Biosimilars by Major Manufacturers 2013-2017
    Table Production Value of Biologics and Biosimilars by Major Manufacturers 2013-2017
    Table Headquarters Location and Established Time of Biologics and Biosimilars Major Manufacturer
    Table Employees and Revenue Level of Biologics and Biosimilars Major Manufacturer
    Table Representative Biologics and Biosimilars Product One of Pfizer
    Table Representative Biologics and Biosimilars Product Two of Pfizer
    Table Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of Pfizer 2013-2017
    Table Representative Biologics and Biosimilars Product One of Roche
    Table Representative Biologics and Biosimilars Product Two of Roche
    Table Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of Roche 2013-2017
    Table Representative Biologics and Biosimilars Product One of Amgen
    Table Representative Biologics and Biosimilars Product Two of Amgen
    Table Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of Amgen 2013-2017
    Table Representative Biologics and Biosimilars Product One of AbbVie
    Table Representative Biologics and Biosimilars Product Two of AbbVie
    Table Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of AbbVie 2013-2017
    Table Representative Biologics and Biosimilars Product One of Sanofi
    Table Representative Biologics and Biosimilars Product Two of Sanofi
    Table Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of Sanofi 2013-2017
    Table Representative Biologics and Biosimilars Product One of Johnson & Johnson
    Table Representative Biologics and Biosimilars Product Two of Johnson & Johnson
    Table Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of Johnson & Johnson 2013-2017
    Table Representative Biologics and Biosimilars Product One of Novo Nordisk
    Table Representative Biologics and Biosimilars Product Two of Novo Nordisk
    Table Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of Novo Nordisk 2013-2017
    Table Representative Biologics and Biosimilars Product One of Novartis
    Table Representative Biologics and Biosimilars Product Two of Novartis
    Table Biologics and Biosimilars Sales, Revenue, Price and Gross Margin of Novartis 2013-2017


List of Figures

    Figure Representative Commercial Product Picture of Biologics and Biosimilars
    Figure Global Shipments Volume Share of Biologics and Biosimilars by Types in 2017
    Figure Representative Commercial Product Picture of Biologics
    Figure Representative Commercial Product Picture of Biosimilars
    Figure Demand Volume Share of Biologics and Biosimilars by Downstream Industry in 2017
    Figure Tumor Examples of Biologics and Biosimilars
    Figure Diabetes  Examples of Biologics and Biosimilars
    Figure Cardiovascular  Examples of Biologics and Biosimilars
    Figure Others  Examples of Biologics and Biosimilars
    Figure Global Biologics and Biosimilars Revenue and Growth Rate 2013-2023
    Figure Global Biologics and Biosimilars Market Size Comparison in 2013, 2017 and 2023
    Figure North America Biologics and Biosimilars Revenue and Growth Rate 2013-2023
    Figure Europe Biologics and Biosimilars Revenue and Growth Rate 2013-2023
    Figure China Biologics and Biosimilars Revenue and Growth Rate 2013-2023
    Figure Japan Biologics and Biosimilars Revenue and Growth Rate 2013-2023
    Figure Rest APAC Biologics and Biosimilars Revenue and Growth Rate 2013-2023
    Figure Latin America Biologics and Biosimilars Revenue and Growth Rate 2013-2023
    Figure Production Volume and Growth Rate of Biologics and Biosimilars 2013-2017
    Figure Production Value and Growth Rate of Biologics and Biosimilars 2013-2017
    Figure Production Volume Share of Biologics and Biosimilars by Regions 2013-2017
    Figure Production Volume Share of Biologics and Biosimilars by Regions in 2013
    Figure Production Volume Share of Biologics and Biosimilars by Regions in 2017
    Figure Production Volume Growth Rate Comparison of Biologics and Biosimilars by Regions 2013-2017
    Figure Production Value Share of Biologics and Biosimilars by Regions 2013-2017
    Figure Production Value Share of Biologics and Biosimilars by Regions in 2013
    Figure Production Value Share of Biologics and Biosimilars by Regions in 2017
    Figure Production Value Growth Rate Comparison of Biologics and Biosimilars by Regions 2013-2017
    Figure Demand Volume Share of Biologics and Biosimilars by Regions 2013-2017
    Figure Demand Volume Share of Biologics and Biosimilars by Regions in 2013
    Figure Demand Volume Share of Biologics and Biosimilars by Regions in 2017
    Figure Demand Volume Growth Rate Comparison of Biologics and Biosimilars by Regions 2013-2017
    Figure Production Volume Share of Biologics and Biosimilars by Types 2013-2017
    Figure Production Volume Share of Biologics and Biosimilars by Types in 2013
    Figure Production Volume Share of Biologics and Biosimilars by Types in 2017
    Figure Production Volume Growth Rate Comparison of Biologics and Biosimilars by Types 2013-2017
    Figure Production Value Share of Biologics and Biosimilars by Types 2013-2017
    Figure Production Value Share of Biologics and Biosimilars by Types in 2013
    Figure Production Value Share of Biologics and Biosimilars by Types in 2017
    Figure Production Value Growth Rate Comparison of Biologics and Biosimilars by Types 2013-2017
    Figure Production Volume Share Forecast of Biologics and Biosimilars by Types in 2023
    Figure Production Value Share Forecast of Biologics and Biosimilars by Types in 2023
    Figure Demand Volume Share of Biologics and Biosimilars by Downstream Industry 2013-2017
    Figure Demand Volume Share of Biologics and Biosimilars by Downstream Industry in 2013
    Figure Demand Volume Share of Biologics and Biosimilars by Downstream Industry in 2017
    Figure Demand Volume Growth Rate Comparison of Biologics and Biosimilars by Downstream Industry 2013-2017
    Figure Demand Volume Share Forecast of Biologics and Biosimilars by Downstream Industry in 2023
    Figure Production Volume Share of Biologics and Biosimilars by Major Manufacturers in 2013
    Figure Production Volume Share of Biologics and Biosimilars by Major Manufacturers in 2017
    Figure Production Value Share of Biologics and Biosimilars by Major Manufacturers in 2013
    Figure Production Value Share of Biologics and Biosimilars by Major Manufacturers in 2017
    Figure Biologics and Biosimilars Revenue and Market Share of Pfizer 2013-2017
    Figure Biologics and Biosimilars Revenue and Market Share of Roche 2013-2017
    Figure Biologics and Biosimilars Revenue and Market Share of Amgen 2013-2017
    Figure Biologics and Biosimilars Revenue and Market Share of AbbVie 2013-2017
    Figure Biologics and Biosimilars Revenue and Market Share of Sanofi 2013-2017
    Figure Biologics and Biosimilars Revenue and Market Share of Johnson & Johnson 2013-2017
    Figure Biologics and Biosimilars Revenue and Market Share of Novo Nordisk 2013-2017

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode
Single User | $(USD)2480 View Pricing